HomeCompareLCAPW vs JNJ

LCAPW vs JNJ: Dividend Comparison 2026

LCAPW yields 136.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LCAPW wins by $15.89M in total portfolio value
10 years
LCAPW
LCAPW
● Live price
136.99%
Share price
$1.46
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.91M
Annual income
$6,531,395.31
Full LCAPW calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LCAPW vs JNJ

📍 LCAPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLCAPWJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LCAPW + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LCAPW pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LCAPW
Annual income on $10K today (after 15% tax)
$11,643.84/yr
After 10yr DRIP, annual income (after tax)
$5,551,686.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LCAPW beats the other by $5,550,982.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LCAPW + JNJ for your $10,000?

LCAPW: 50%JNJ: 50%
100% JNJ50/50100% LCAPW
Portfolio after 10yr
$7.97M
Annual income
$3,266,111.55/yr
Blended yield
41.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LCAPW
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LCAPW buys
0
JNJ buys
0
No recent congressional trades found for LCAPW or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLCAPWJNJ
Forward yield136.99%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$15.91M$20.0K
Annual income after 10y$6,531,395.31$827.78
Total dividends collected$14.62M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LCAPW vs JNJ ($10,000, DRIP)

YearLCAPW PortfolioLCAPW Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$24,399$13,698.63$10,676$355.77+$13.7KLCAPW
2$57,343$31,236.24$11,407$389.39+$45.9KLCAPW
3$129,967$68,610.14$12,198$426.53+$117.8KLCAPW
4$284,396$145,331.12$13,056$467.62+$271.3KLCAPW
5$601,515$297,211.14$13,987$513.12+$587.5KLCAPW
6$1,231,116$587,495.29$14,998$563.56+$1.22MLCAPW
7$2,441,054$1,123,759.56$16,098$619.52+$2.42MLCAPW
8$4,694,346$2,082,418.44$17,295$681.69+$4.68MLCAPW
9$8,765,624$3,742,673.91$18,599$750.82+$8.75MLCAPW
10$15,910,613$6,531,395.31$20,022$827.78+$15.89MLCAPW

LCAPW vs JNJ: Complete Analysis 2026

LCAPWStock

Lionheart Acquisition Corporation II intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its efforts in businesses that apply digital technologies and technology-enhanced services and solutions to the identification, design, development, construction, operation, financing, management, and disposition of real estate properties. The company was founded in 2019 and is based in Miami, Florida.

Full LCAPW Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LCAPW vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LCAPW vs SCHDLCAPW vs JEPILCAPW vs OLCAPW vs KOLCAPW vs MAINLCAPW vs ABBVLCAPW vs MRKLCAPW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.